Unlock the answers to your additive manufacturing questions when you register for our webinar, Opportunities and Challenges in Additive Manufacturing in the Time of COVID-19, taking place on Wednesday, January 13, from 12-1 pm ET.

Before making big decisions associated with additive manufacturing (AM), it’s important to gain a realistic view of the technology and recognize what stands in the way of its acceptance. While adoption of AM in the aerospace, automotive, and medical industries continues toward development, hurdles may exist. It can be difficult to distinguish the hype, mistruths, and facts, so question and validate everything you read and hear.

Terry Wohlers will help you gain a better understanding about AM and explore how the pandemic might affect business going into 2021 and beyond! 

Click here to learn more and reserve your spot now. Don’t forget to add the webinar to your calendar. Can’t participate on the day of the event? No problem. Each registered attendee will also receive a link to the recording. This content will be sent within 7-10 business days after the event. 

REGISTER Now! 

GIE Media's Manufacturing Group wishes everyone the best in 2021!

Healthcare spending will grow to $6 trillion annually, an average of 5.5% compound annual growth rate (CAGR) to 2027, according to The Centers for Medicare and Medicaid Services. That growth continues boosting demand for medical devices. Valued at $425.5 billion in 2018, the global medical device market is forecast to reach $612.7 billion by 2025, registering a 5.4% CAGR. A growing global medical device market leads to expanded medical device outsourcing, with Reports and Data indicating that the global medical device outsourcing market, valued at $96.6 billion in 2018 will reach $208.4 billion by 2026, a CAGR of 10.1%.

Beyond these strong forecasted numbers, 2020 also began with the permanent repeal of the medical device tax (see Regulatory, pg. 16) and the growing, aging population where globally, there are more centenarians than at any point in history and average life expectancy has increased from 67 to 72 in the past 20 years. And, while connected technology has been quickly adapted by younger generations, 76% of those 65 and older report that connected care technology is important to enable them to age at home; the market is projected to grow at a CAGR of 30.27% through 2025, reaching $232.9 billion.

Read the full article here.

Medical device manufacturers must establish and follow quality systems in accordance with U.S. Food and Drug Administration (FDA) current good manufacturing practices (CGMP) to ensure that devices are safe and function as intended. The quality system regulation (QSR) doesn’t prescribe how to produce a specific device, but states manufacturers “should use good judgment when developing their quality system and apply those sections of the QSR that apply to their products and operations.”

It’s the manufacturer’s responsibility to establish the appropriate methods and procedures to design, produce, distribute, and deliver devices meeting these requirements, which involves creating or selecting a quality management system (QMS).